Search

Search Constraints

You searched for: Author/Creator Rudin, Charles M.

Search Results

1. A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer. (September 2016)

2. A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer. Issue 4 (April 2015)

3. Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study. (March 2019)

6. Clinical outcomes, local–regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab. (August 2020)

7. Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions. (September 2021)

8. Combining the pan‐aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer. (3rd July 2014)

9. Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66–73]. (December 2021)